New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Decline A trial of donanemab, an experimental drug, found it modestly [...] By digitalstudios|2023-07-17T14:30:32+00:00July 17, 2023|3rd Party Pharmaceutical Industry News|Comments Off on New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Decline Read More